Award
National Cancer Institute 5R01CA292925-02
Identifying Multi-Level Predictors and Outcomes of Oral Anticancer Medication Adherence Initiation and Persistence among Patients with Hematologic Malignancies
Recipient
University of Pittsburgh at Pittsburgh, Pittsburgh, PA
Award Amount
$626,631.00
Ceiling
$626,631.00
Awarded
September 05, 2025
Identifier
5R01CA292925-02
A research project funded by the National Cancer Institute to study factors affecting adherence to oral anticancer medications among patients with hematologic malignancies, aiming to improve medication adherence and health outcomes.
Description
This study describes how long it takes patients to start their cancer pills and how they take them over time; identifies barriers they may face; and how patients’ health may be affected by their ability to start and continue taking their cancer pills. It aims to develop targeted interventions to improve adherence to oral cancer medications and health outcomes among patients with hematologic malignancies.